Skip to main content
logo
Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
66.23
+2.55 (4.00%)
At close: Oct 20, 2026, 4:00 PM EDT
66.20
-0.03 (-0.05%)
After-hours: Oct 20, 2026, 7:41 PM EDT

Vaxcyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10,4246,04010,2035,9763,7871,256
Market Cap Growth
89.42%-40.80%70.74%57.79%201.58%-7.24%
Enterprise Value
9,0534,4138,0504,7243,445978
Last Close Price
66.2346.1481.8662.8047.9523.79

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.482.253.094.823.974.42
P/TBV Ratio
3.782.253.094.823.974.42

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.040.020.020.020.06
Net Debt / Equity Ratio
-0.50-0.54-0.51-0.85-0.96-0.81
Net Debt / EBITDA Ratio
1.191.592.982.263.982.25
Net Debt / FCF Ratio
1.492.032.932.885.181.79
Quick Ratio
5.487.8112.637.4623.088.61
Current Ratio
5.727.9112.767.5423.268.93
Return on Equity (ROE)
-36.51%-25.59%-20.41%-36.67%-36.12%-31.78%
Return on Assets (ROA)
-22.61%-17.72%-14.47%-24.23%-21.82%-18.07%
Return on Capital Employed (ROCE)
-40.60%-33.00%-16.90%-37.10%-24.10%-35.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.21%-12.69%-4.55%-6.73%-5.90%-7.97%
FCF Yield
-8.84%-11.80%-5.60%-6.10%-4.66%-10.19%
Buyback Yield / Dilution
-4.88%-11.55%-25.57%-49.75%-24.95%-75.73%
SEC Filings: 10-K · 10-Q